FINRA issued its 2025 Annual Regulatory Oversight Report, providing a detailed look into FINRA’s current regulatory oversight ...

Speaking this week at BIO CEO, the heads of Septerna, Upstream Bio and Actuate Therapeutics shared lessons from going public ...

The subscription will remain open for both public issues till February 18, followed by the process of finalisation of IPO ...

Many privately owned businesses fear offering shares to the stock market, largely because of the rigorous listing ...